Medical Research
Follow Medical Research in the Factlen app and get an alert when there is news. Get the app
- All Health
- Nutrition & Diet
- Supplements
- Mental Health
- Sleep
- Longevity
- Medicine
- Medications & Treatments
- Conditions & Diseases
- Hormones & Endocrinology
- Skincare
- Dental Health
- Family Health
- Children's Health
- Men's Health
- Women's Health
- Aging & Geroscience
- Biohacking
- Alternative Medicine
- Public Health
- Medical Research
- Preventive Wellness
- Healthy Habits
Research Brief
New Drug Lifyorli Reduces Risk of Death by 35% in Phase 3 Trial for Platinum-Resistant Ovarian Cancer
4 sources · 106d ago
Research Brief
Landmark Phase 3 Trial: New Oral GLP-1 Pill Orforglipron Outperforms Semaglutide for Weight Loss and Diabetes Control
3 sources · 106d ago
Explainer
Scientists Identify DEAF1 Gene as the Molecular Switch That Allows Exercise to Reverse Muscle Aging
3 sources · 107d ago
More in Medical Research
Research BriefADHD Innovation
First-in-Class NDSRI Centanafadine Poised to Reshape ADHD Treatment for All Ages
Clinical Psychiatrists 40%Neuropharmacology Researchers 30%Patient Advocates 30%
ExplainerPsychedelic Therapy
White House Mandate Cuts FDA Review of Psychedelic Therapies to Weeks
Clinical Researchers & Drug Sponsors 40%Veteran & Patient Advocates 35%Regulatory Skeptics 25%
Deep DiveGenetic Medicine
New Gene Editor Overcomes CRISPR's Size Limit, Making Million-Base-Pair Edits Possible for Large-Gene Disorders
Genetic Medicine Researchers 40%Biotech & Delivery Innovators 35%Bioethics & Safety Monitors 25%
ExplainerBiosecurity
Global Biosecurity Frameworks Deemed 'Obsolete' as AI and DNA Synthesis Outpace Regulation
Biosecurity Researchers 40%Policy & Non-Proliferation Advocates 35%Scientific Innovation Defenders 25%
Deep DiveType 1 Diabetes
First Patient Achieves Sustained Insulin Independence Following Autologous Stem Cell-Derived Islet Transplant
Regenerative Medicine Researchers 40%Clinical Endocrinologists 30%Health Economists 30%
ExplainerPediatric Oncology
Landmark CAR-T Trial Achieves Complete Tumor Elimination in Child With Previously Incurable Brain Cancer
Clinical Trial Investigators 39%Cellular Engineering Researchers 33%Pediatric Cancer Advocates 28%
ExplainerNeuroimmunology
Scientists Map Brainstem Circuit That Directly Controls Body Inflammation, Opening New Era in Immunology
Neuroimmunologists 45%Bioelectronic Innovators 35%Clinical Skeptics 20%
Research BriefVaccine Tech
Single Nasal Vaccine Protects Against Flu, COVID, and Allergies in Early Trials
Immunology Researchers 40%Public Health & Policy Analysts 35%Allergy Specialists 25%
ExplainerOncology Breakthrough
Landmark Immunotherapy Trial Achieves 33% Three-Year Survival in Previously Untreatable MSS Colorectal Cancer
Clinical Oncologists 40%Immunology Researchers 35%Patient Advocates & Ethicists 25%
ExplainerOrexin Agonists
First-in-Class Orexin Agonist Oveporexton Shows Significant Improvement in Wakefulness for Narcolepsy Type 1 in Landmark Phase 3 Trials
Sleep Medicine Researchers 41%Patients & Advocacy Groups 35%Industry Analysts 24%
Longevity Science
Harvard Scientists Discover Chemical Cocktail to Reverse Cellular Aging
Longevity Researchers 45%Scientific Skeptics 35%Bioethics & Accessibility Advocates 20%
ExplainerMotor Neurone Disease
How a New Drug Targeting the C5aR2 Receptor Could Turn Motor Neurone Disease Into a Chronic Condition
Structural Biologists 35%Patient Advocacy Groups 35%Clinical Neurologists 30%
Biotech M&AOncology Breakthrough
Novartis Acquires Cancer Drug Startup Myricx Bio for $1.1 Billion Upfront to Enter Next-Gen ADC Market
Big Pharma Acquirers 41%Biotech Innovators 35%Clinical Oncology 24%
ExplainerOncology Fitness
Clinical Data Confirms Structured Exercise is Essential Cancer Treatment, Cutting Mortality Risk by 37%
Clinical Oncology Consensus 50%Exercise Science Researchers 35%Integrative Health Analysts 15%
ExplainerLung Cancer Therapy
Landmark Trial: Bispecific Antibody Ivonescimab Achieves 34% Survival Advantage Over Standard Immunotherapy in Lung Cancer
Clinical Oncologists 40%Biopharma Analysts 35%Evidence Skeptics 25%
ExplainerBundibugyo Virus
WHO Launches Landmark Global Trial to Find First Effective Treatments for Bundibugyo Virus
Global Health Authorities 35%Clinical Researchers 35%Frontline Responders 29%
Regenerative DentistryMedical Breakthrough
Protein-Based Gel Mimics Amelogenin to Regenerate Lost Enamel, Offering First Functional Repair for Tooth Decay
Regenerative Dental Researchers 40%Clinical Dentists 35%Public Health Skeptics 25%
ExplainerAlzheimer's Biomarkers
Landmark Study: Circular RNA Blood Test Outperforms Gold Standard in Predicting Alzheimer's Progression
Diagnostic Innovators 45%Clinical Trialists 35%Cautious Methodologists 20%
Research BriefBrain Plasticity
Non-Invasive Light Therapy Reopens 'Critical Period' Brain Plasticity by Dismantling Neural Nets
Clinical Neurologists 44%Basic Neuroscientists 39%Neuroethics Researchers 17%
Bioethics Framework
How the Global Scientific Community is Building Ethical Guardrails for Human Gene Editing
Therapeutic Advocates 40%Precautionary Bioethicists 40%Regulatory Framework Builders 20%
Research BriefRenal Cell Carcinoma
FDA Approves Belzutifan and Pembrolizumab Combination as New Standard for High-Risk Kidney Cancer
Clinical Oncologists 45%Clinical Trial Investigators 35%Regulatory Authorities 20%
Research BriefOncology Breakthrough
Landmark Trial Adds Immunotherapy to Chemo, Halving Recurrence Risk in Stage III dMMR Colon Cancer
Clinical Oncologists 40%Patient Advocacy Groups 30%Regulatory & Industry Analysts 30%
AI in ScienceBreakthrough
Google DeepMind Leaders Win Nobel Prize in Chemistry for AlphaFold Protein Breakthrough
Medical & Biological Researchers 45%AI & Computer Scientists 35%Open Science Advocates 20%
Thyroid Eye Disease
FDA Approves Lumvoa, First IGF-1R Inhibitor to Treat Thyroid Eye Disease
Clinical Ophthalmologists 35%Patient Advocacy Groups 35%Industry Analysts 30%
ExplainerHER2 Therapies
FDA Approves T-DXd for Early-Stage HER2+ Breast Cancer, Signaling New Standard of Care
Clinical Researchers 47%Regulatory Monitors 35%Industry Analysts 18%
InjuryGlobal Chess
Chess Injury and Health Report: L'Ami's Resurgence, McConnell's Master Title, and Vyas's Return
Therapeutic Advocates 40%Recovering Competitors 35%Medical Professionals 25%
Research BriefPrecision Immunology
First-in-Class Extracellular Protein Degrader Enters Phase 3 to Target Root Cause of Graves' Disease
Clinical Trial Investigators 41%Targeted Protein Degradation Pioneers 29%Biotech Industry Analysts 29%
Cancer ScreeningClinical Trial Results
Single Blood Test Successfully Screens for 50 Cancers in Landmark 140,000-Person Trial
Oncology Researchers 45%Public Health Evaluators 35%Patient Advocacy Groups 20%
Deep DiveCartilage Regeneration
Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis
Regenerative Medicine Researchers 40%Orthopedic Specialists 35%Public Health & Patient Advocates 25%
ExplainerPsychedelic Medicine
Phase 3 Trial Shows Non-Hallucinogenic LSD Derivative DT120 Treats Major Depression
Clinical Researchers 40%Regulatory & Policy Experts 30%Factlen Editorial Synthesis 30%
Research BriefImmunopsychiatry
Anti-Inflammatory Drug Achieves 54% Remission in Hard-to-Treat Depression by Targeting Immune System
Immunopsychiatry Researchers 44%Mainstream Psychiatrists 33%Precision Medicine Advocates 22%
KRAS Inhibitors
Next-Gen KRAS Inhibitor Divarasib Achieves Superior Overall Survival in Landmark Lung Cancer Trial
Clinical Oncologists 40%Pharmaceutical Analysts 35%First-Generation Developers 25%
Research BriefMantle Cell Lymphoma
Landmark Phase 3 Trial Establishes Chemotherapy-Free Regimen as New Standard for Frontline Mantle Cell Lymphoma
Clinical Hematologists 41%Patient Advocates 29%Regulatory Analysts 29%
ExplainerBreast Cancer
Landmark Study Finds Intraoperative PET-CT Significantly Reduces Re-Operation Rates in Breast-Conserving Surgery
Surgical Oncologists 40%Radiology & Imaging Experts 35%Patient Advocates & Trialists 25%
ExplainerBioprinted Organs
Bioprinted Adrenal Tissue Restores Circadian Cortisol in Animal Models, Offering Functional Cure for Addison's Disease
Regenerative Medicine Researchers 45%Patient Advocacy Groups 35%Endocrinologists 20%
Research BriefPrecision Medicine
NIH's All of Us Program Unveils World's Largest Integrated Genomic and Clinical Dataset for Precision Medicine
Precision Medicine Researchers 40%Health Equity Advocates 35%Medical Informaticians 25%
Deep DiveAlzheimer's Research
Karyoptosis Discovery Reveals the Cell Death Pathway That Kills Alzheimer's Neurons
Basic Researchers 40%Translational Medicine Community 35%Patient Advocacy Organizations 25%
ExplainerPrecision Nutrition
Landmark PREDICT Study Finds Metabolic and Inflammatory Response to Food is Highly Personalized, Not Universal
Precision Nutrition Advocates 45%Public Health Traditionalists 35%Health Equity Researchers 20%
Deep DiveAlzheimer's Research
Brain Protein 'Arc' Acts as a Trojan Horse for Toxic Tau, Revealing New Target to Stop Alzheimer's Spread
Neurobiology Researchers 40%Translational Medicine Developers 35%Clinical Neurologists 25%
ExplainerLipoprotein(a)
Landmark Phase 3 Trial: RNA-Targeted Drug Pelacarsen Significantly Reduces Heart Attacks by Neutralizing Untreatable Lp(a)
Preventive Cardiologists 40%Health Economists and Payers 30%Genetic Medicine Researchers 30%
ExplainermRNA Vaccines
Personalized mRNA Cancer Vaccines Advance to Phase 3 Trials for Pancreatic Cancer and Melanoma
Clinical Oncologists 40%Biotech Developers 35%Evidence Analysts 25%
ExplainerGLP-1 Therapeutics
Semaglutide Reduces Symptoms and Improves Physical Function in Patients With HFpEF
Clinical Cardiologists 45%Cardiovascular Researchers 35%Health Economists 20%
ExplainerBiomedical AI
AI Model 'MAMMAL' Outperforms AlphaFold 3, Signaling a New Era for Multimodal Drug Discovery
Computational Biologists 44%Open-Source Advocates 31%Structural Biologists 25%
Genetic MedicineEvidence Pack
First-Ever Bespoke Base-Editing Therapy Developed in Months Saves Infant with Rare Genetic Disease
Clinical Geneticists & Researchers 40%Regulatory & Public Health Officials 35%Medical Ethicists & Skeptics 25%
ExplainerHeart Failure
Landmark Global Consensus Redefines Heart Failure, Updating Diagnosis and Treatment for 64 Million People
Cardiology Societies 40%Global Health Advocates 30%Clinical Synthesis 30%
Deep DiveLong COVID
Landmark Trials Test Existing Drugs to Treat Long COVID by Targeting Inflammation and Blood Flow
Clinical Researchers 40%Patient Advocacy Groups 30%Vascular Biologists 30%
Per page